top of page
香港大學生物醫藥技術國家重點實驗室
State Key Laboratory of Pharmaceutical Biotechnology
The University of Hong Kong
Ongoing Fundings
Ongoing Fundings
Grant Type | Project Title | Amount | Start Date | Completion Date | Principal Investigator |
|---|---|---|---|---|---|
Area of Excellence (AoE/M-707/18) | Institute of Metabolic Medicine | 77,803,000.00 | 01/05/2019 | 30/04/2027 | Prof. Aimin XU |
General Research Fund (GRF) (17102920) | TRIF as a novel regulator of lipid droplet enlargement in visceral adipocytes | $1,125,732 HKD | 01/09/2021 | 31/08/2024 | Dr. Connie Wai Hong WOO |
General Research Fund (GRF) (17127121) | Does Hippocampus Modulate Central Auditory Processing? A Functional MRI Study | $ 1,351,372 HKD | 01/09/2021 | 31/08/2024 | Prof. Ed Xuekui WU |
CAS - Croucher Funding Scheme for Joint Laboratories | Discovery and Development of Innovative Antibody Drugs for Metabolic and Cardiovascular Diseases | $ 3,750,000 HKD | 01/03/2021 | 29/02/2024 | Prof. Aimin XU |
国家自然科学基金-面上项目 (82070860) | 成纤维细胞生长因子21在运动改善糖尿病心肌病过程中的作用机制研究 | ￥690,800 CNY | 01/01/2021 | 31/12/2024 | Prof. Aimin XU |
General Research Fund (GRF) (17117320) | The mechano-sensitive ion channel Piezo1 balances the conversion of mesenchymal stem cells to osteoblasts and bone marrow adipocytes | $ 1,195,542 HKD | 01/01/2021 | 31/12/2023 | Prof. Aimin XU |
国家自然科学基金青年项目（82000832） | 机械敏感离子通道Piezo1通过调控骨髓脂肪细胞形成对全身代谢的作用及机理研究 | ￥240,000 CNY | 01/01/2021 | 31/12/2023 | Dr. Baile WANG |
国家自然科学基金青年项目（32000816） | 脂肪组织葡萄糖转运蛋白GLUT1对成纤维细胞生长因子21的调控 | ￥240,000 CNY | 01/01/2021 | 31/12/2023 | Dr. Leiluo GENG |
广东省自然科学基金-面上项目 (2021A1515010841) | Th17激活在运动干预防治糖尿病效果中的作用及其机制研究 | $ 125,600 HKD | 01/01/2021 | 31/12/2023 | Dr. Yan LIU |
GRF (17117320) | The mechano-sensitive ion channel Piezo1 balances the conversion of mesenchymal stem cells to osteoblasts and bone marrow adipocytes | 1,195,542.00 | 01/01/2021 | 31/12/2023 | Prof. Aimin XU |
MERCK SHARP & DOHME (ASIA) LTD | Identification of metabolic factors involved in NASH progression in morbidly obese | $482,686 USD | 16/11/2020 | 15/11/2023 | Prof. Aimin XU |
Early Career Scheme (ECS) (27115220) | Low-irradiance red light-triggered drug release for the treatment of retinoblastoma | 986,520.00 | 01/09/2020 | 31/08/2023 | Dr. Weiping WANG |
HMRF (07181936) | Development of photo-targeted nanocarriers for esophageal cancer therapy | 1,405,630.00 | 01/09/2020 | 31/08/2023 | Dr. Weiping WANG |
GRF (17124420) | Adiponectin-expressing thymic Treg for adoptive immunotherapy in obesity and metabolic diseases | 996,285.00 | 01/08/2020 | 31/07/2023 | Dr. Yu WANG |
HMRF (07182516) | ANNEXIN A8 as a novel adipokine mediating visceral obesity-associated metabolic complications | 1,484,540.00 | 16/07/2020 | 15/07/2023 | Dr. Xiaoyan HUI |
HMRF (07182726) | Implementation of multi-biomarkers algorithm for detection in Chinese obese individuals with non-alcoholic fatty liver disease | 1,497,244.00 | 01/07/2020 | 30/06/2023 | Dr. Kwan Yui Cynthia CHEUNG |
HMRF (07182836) | Role of the mechano-sensitive ion channel Piezo1 in the regulation of obesity and adaptive thermogenesis: molecular mechanisms and clinical implications | 1,482,400.00 | 01/04/2020 | 31/03/2023 | Dr Baile WANG |
GRF (17118619) | Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signaling | 1,157,363.00 | 01/01/2020 | 31/12/2022 | Dr. Zhengyuan XIA |
NSFC Young Excellent Scientist fund | Mechanistic study of adipose browning | 1,300,00.00 (RMB) | 01/01/2020 | 01/01/2023 | Dr. Xiaoyan HUI |
GRF (17101819) | Syndecan-4 (Sdc4) as a key regulator of white adipose tissue browning for energy expenditure | 1,113,341.00 | 01/01/2020 | 31/12/2022 | Dr. Ruby Lai Chong HOO |
GRF (17121819) | The Single Transmembrane Protein β-klotho as a Novel Regulator of Insulin Secretion in Pancreatic β-cells | 1,684,895.00 | 01/01/2020 | 31/12/2022 | Prof. Aimin XU |
GRF (17123419) | Thyroid hormone induces facultative thermogenesis in white adipose tissue through UCP1-independent mechanism | 957,916.00 | 01/10/2019 | 30/09/2022 | Dr. Xiaoyan HUI |
HMRF (06172346) | AMPK γ2 as a master regulator of adipokine transcription: biological function, molecular mechanism and clinical implications | 1,449,248.00 | 16/09/2019 | 15/09/2022 | Dr. Xiaoyan HUI |
HMRF (06172266) | Exploring the role of microRNA in sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes | 1,499,956.00 | 01/08/2019 | 31/07/2022 | Dr. Yu Yan CHEUNG |
GRF (06173456) | Development of ultrasound-responsive polymeric nanoreactors for retinoblastoma therapy | 1,499,628.00 | 01/08/2019 | 31/07/2022 | Dr. Weiping WANG |
HMRF (06172446) | Autotaxin as a potential mediator of obesity-related metabolic complications | 1,496,996.00 | 15/07/2019 | 14/07/2022 | Prof. Aimin XU |
HMRF (06172636) | Targeting G protein-coupled receptor 110 for the treatment of obesity and non-alcoholic fatty liver disease | 1,399,248.00 | 30/04/2019 | 30/04/2022 | Dr. Zhe HUANG |
GRF (17121520) | Androgen regulates white adipose tissue remodelling via suppression of PRDM16 | 1,145,727.00 | 01/01/2021 | 31/12/2023 | Dr. Xiaoyan HUI |
bottom of page